Clinical analysis of ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy for postoperative abdominal malignant tumor without ascites

Abstract

Objective \nTo investigate the clinical value of ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy for postoperative abdominal malignant tumor without ascites. \n \n \nMethods \nA retrospective analysis were performed in 146 postoperative patients with abdominal malignancies who were admitted to Fujian Cancer Hospital from April 2013 to September 2018, and there were no ascites founded in these patients before abdominal catheterization. Two hundred and seventy-nine times ultrasound-guided catheterization in intraperitoneal perfusion chemotherapy were performed under clinical guidance. \n \n \nResults \nTwo hundred and seventy-seven times abdominal catheterization was completed, with a success rate of 99.3%(277/279), and the one-time success rate was 83.2% (232/279), 2 times (0.7%, 2/279) had to be abandoned for peritoneal adhesions. Fifty-three patients (36.3%, 53/146) underwent catheterization ≥ 2 times. The intraperitoneal perfusion chemotherapy was successfully completed after catheterization, no intestinal injury and bleeding occurred. \n \n \nConclusions \nIn the absence of ascites, ultrasound guided catheterization in perfusion chemotherapy is safe, reliable, simple, accurate and has a high success rate. This new approach is good for clinical application when the conventional catheterization with ascites is blocked. \n \n \nKey words: \nChemotherapy, cancer, regional perfusion;\xa0Intraperitoneal perfusion chemotherapy;\xa0Catheterization;\xa0Ultrasound